You are here

Article Text

Article menu
Download PDFPDF
Best practice
Fifteen-minute consultation: Investigation and management of hypoglycaemia in the term-born infant
  1. Daniel Cromb1,2,
  2. Malgorzata Radomska2,
  3. Nandu Thalange3,
  4. Paul Cawley1,2
  1. 1 Centre for the Developing Brain, Department of Perinatal Imaging and Health, School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK
  2. 2 Department of Neonatology, Evelina London Children's Hospital, London, UK
  3. 3 Department of Paediatric Endocrinology, Al Jalila Children's Specialty Hospital, Dubai, UAE
  1. Correspondence to Dr Daniel Cromb, Centre for the Developing Brain, Department of Perinatal Imaging and Health, School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London SE17EH, UK; daniel.cromb{at}nhs.net

Abstract

Hypoglycaemia in term infants is very common. Deciding on appropriate investigations and management is often challenging. The aims of this article are to help with understanding when, how and why to investigate symptoms of hypoglycaemia in full-term infants (born ≥37 weeks’ gestational age).

  • neonatology
  • intensive care units, neonatal
  • endocrinology

https://doi.org/10.1136/archdischild-2021-323568

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @dancromb, @PaulCawleyUK

    • Contributors DC conceived of and wrote the article, and designed flowcharts 1–3. MR reviewed the article and created flowchart 3. NT reviewed the article. PC reviewed the article and helped design flowcharts 1–3.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; externally peer reviewed.